Prognostic value of the GRANT score and development of a nomogram in papillary renal cell carcinoma: a SEER-based study with external validation in a Chinese cohort
This study validates the GRANT score as an independent prognostic factor in a large pRCC cohort. The developed and externally validated nomogram provides a clinically useful tool with robust performance, particularly for predicting CSS, facilitating personalized risk assessment and postoperative management for pRCC patients.
Authors
- Yu Yao (ORCID: https://orcid.org/0000-0003-3618-2363)
- Tongpeng Liu (ORCID: https://orcid.org/0009-0008-0459-5116)
- Wei Chen (ORCID: https://orcid.org/0000-0003-0903-7945)
- Lijiang Sun (ORCID: https://orcid.org/0000-0001-5856-8270)
- Yang Hu (ORCID: https://orcid.org/0000-0001-7279-0505)
- Gui-Ming Zhang
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.3389/fonc.2025.1659055
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00